Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

23.07

+0.36 (1.59%)

Feb 24, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology	61.00K	130.00K	84.68M	10.65M	7.76M
Biotechnology Growth	-53.08%	-99.85%	695.15%	37.31%	1080.52%
Total	61.00K	130.00K	84.68M	10.65M	7.76M
Total Growth	-53.08%	-99.85%	695.15%	37.31%	1080.52%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	61.00K	130.00K	84.68M	10.65M	7.76M
United States Growth	-53.08%	-99.85%	695.15%	37.31%	1080.52%
Total	61.00K	130.00K	84.68M	10.65M	7.76M
Total Growth	-53.08%	-99.85%	695.15%	37.31%	1080.52%

Source: S&P Global Market Intelligence.